Enzyme Therapy for Coeliac Disease: Is It Ready For Prime Time?

Cornell,; Stelmasiak, T

doi:10.5772/50247

Search citation statements

Order By: Relevance

Paper Sections

Select...

Introduction1

Reduction In Absorbance (%)1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2015

2016

Publication Types

Select...

Article2

Relationship

Self Cite1

Independent1

Authors

Journals

Cited by 2 publications

(2 citation statements)

References 78 publications

(85 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Stepniak et al (2006) have identified a prolyl endopeptidase from Aspergillus niger that is able to degrade T-cell stimulatory peptides in vitro. It is also suspected that caricain, which contains endopeptidases, can achieve detoxification by digestion of immunoactive fragments of gluten (Cornell & Stelmasiak, 2007, 2012.…”

Section: Introductionmentioning

confidence: 98%

Reduction of toxic gliadin content of wholegrain bread by the enzyme caricain

2015

View full text Add to dashboard Cite

Section: Introductionmentioning

confidence: 98%

Reduction of toxic gliadin content of wholegrain bread by the enzyme caricain

2015

View full text Add to dashboard Cite

“…The results of these experiments are promising and add to the body of knowledge gained from mucosal digestion of natural and synthetic peptides and the use of caricain for supplementary digestion of the gliadin (Cornell & Stelmasiak, 2012). It must be understood that the immunoassay results are not necessarily related to toxicity in the same way as the results of the lysosome assay.…”

Section: Reduction In Absorbance (%)mentioning

confidence: 87%